1. Ahuka-Mundeke S, Casey RM, Harris JB, Dixon MG, Nsele PM, Kizito GM, Umutesi G, Laven J, Paluku G, Gueye AS, Hyde TB, Sheria GKM, Muyembe-Tanfum JJ, Staples JE (2018) Immunogenicity of fractional-dose vaccine during a yellow fever outbreak—preliminary report. N Engl J Med.
https://doi.org/10.1056/nejmoa1710430
2. Baumgaertner E (2016) Could yellow fever become the next pandemic? Sci Am.
https://www.scientificamerican.com/article/could-yellow-fever-become-the-next-pandemic/
3. Brent SE, Watts A, Cetron M, German M, Kraemer MUG, Bogoch II, Brady OJ, Hay SI, Creatore MI, Khan K (2018) International travel between global urban centres vulnerable to yellow fever transmission. Bull World Health Organ 96:343–354B
4. Brey PT, Fontenille D, Tang H (2018) Yellow fever risk in Asia-Pacific region. Nature 554:31
5. Centers for Disease Control and Prevention (CDC) (2017) Clinical update announcement: temporary total depletion of US licensed yellow fever vaccine addressed by availability of Stamaril vaccine at selected clinics. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) and Division of Vector-Borne Diseases (DVBD).
https://wwwnc.cdc.gov/travel/news-announcements/yellow-fever-vaccine-access